Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin
Today, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinical benefit of combination antiviral therapy in pat...
Saved in:
| Main Authors: | , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2006-01-01
|
| Series: | Canadian Journal of Gastroenterology |
| Online Access: | http://dx.doi.org/10.1155/2006/497059 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832561800270315520 |
|---|---|
| author | Morris Sherman Lawrence Cohen Mary Anne Cooper Magdy Elkashab Victor Feinman David Fletcher Nigel Girgrah Jenny Heathcote Mark Levstik William B McNaull David Wong Florence Wong Colina Yim |
| author_facet | Morris Sherman Lawrence Cohen Mary Anne Cooper Magdy Elkashab Victor Feinman David Fletcher Nigel Girgrah Jenny Heathcote Mark Levstik William B McNaull David Wong Florence Wong Colina Yim |
| author_sort | Morris Sherman |
| collection | DOAJ |
| description | Today, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinical benefit of combination antiviral therapy in patients coinfected with HCV and HIV, and in patients who have received a liver transplant. |
| format | Article |
| id | doaj-art-d104cc8cf49a4d9b8ea2a3e3f5352f7a |
| institution | Kabale University |
| issn | 0835-7900 |
| language | English |
| publishDate | 2006-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Canadian Journal of Gastroenterology |
| spelling | doaj-art-d104cc8cf49a4d9b8ea2a3e3f5352f7a2025-02-03T01:24:11ZengWileyCanadian Journal of Gastroenterology0835-79002006-01-0120747948510.1155/2006/497059Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with RibavirinMorris Sherman0Lawrence Cohen1Mary Anne Cooper2Magdy Elkashab3Victor Feinman4David Fletcher5Nigel Girgrah6Jenny Heathcote7Mark Levstik8William B McNaull9David Wong10Florence Wong11Colina Yim12Toronto General Hospital, University of Toronto, CanadaSunnybrook and Women’s College Health Sciences Centre and Faculty of Medicine, University of Toronto, CanadaSunnybrook and Women’s College Health Sciences Centre and Faculty of Medicine, University of Toronto, CanadaNorth York General Hospital, University of Toronto, CanadaMount Sinai Hospital and Faculty of Medicine, University of Toronto, CanadaMaple Leaf Medical Clinic, University of Toronto, Toronto, CanadaToronto General Hospital, University of Toronto, CanadaToronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, CanadaLondon Health Sciences Centre and Schulich School of Medicine, University of Western Ontario, London, Ontario, CanadaMount Sinai Hospital and Faculty of Medicine, University of Toronto, CanadaToronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, CanadaToronto General Hospital, University of Toronto, CanadaToronto Western Hospital and Faculty of Medicine, University of Toronto, Toronto, CanadaToday, combination antiviral therapy with pegylated interferon-alpha and ribavirin (RBV) allows many patients infected with hepatitis C virus (HCV) to achieve a sustained virological response, which is equivalent to cure. Data also support the clinical benefit of combination antiviral therapy in patients coinfected with HCV and HIV, and in patients who have received a liver transplant.http://dx.doi.org/10.1155/2006/497059 |
| spellingShingle | Morris Sherman Lawrence Cohen Mary Anne Cooper Magdy Elkashab Victor Feinman David Fletcher Nigel Girgrah Jenny Heathcote Mark Levstik William B McNaull David Wong Florence Wong Colina Yim Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin Canadian Journal of Gastroenterology |
| title | Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin |
| title_full | Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin |
| title_fullStr | Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin |
| title_full_unstemmed | Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin |
| title_short | Clinical Recommendations for the Use of Recombinant Human Erythropoietin in Patients with Hepatitis C Virus Being Treated with Ribavirin |
| title_sort | clinical recommendations for the use of recombinant human erythropoietin in patients with hepatitis c virus being treated with ribavirin |
| url | http://dx.doi.org/10.1155/2006/497059 |
| work_keys_str_mv | AT morrissherman clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT lawrencecohen clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT maryannecooper clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT magdyelkashab clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT victorfeinman clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT davidfletcher clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT nigelgirgrah clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT jennyheathcote clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT marklevstik clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT williambmcnaull clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT davidwong clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT florencewong clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin AT colinayim clinicalrecommendationsfortheuseofrecombinanthumanerythropoietininpatientswithhepatitiscvirusbeingtreatedwithribavirin |